Advanced Filters
noise

Dementia Clinical Trials

A listing of Dementia medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Found 839 clinical trials
M Mark Rapp, MD

Triage Survey for Neurology Research Eligibility

TRIAGE-Neuro is a survey study designed to assess potential participants' eligibility to screen for industry-sponsored neurology clinical trials.

18 years of age All Phase N/A
J Jianping Jia, Doctor

Detection of Alzheimer's Disease (AD)-Related Seeds for AD Diagnosis

The study will investigate the biomarkers of Aβ and Tau seeds in plasma detected by Alzheimer's disease (AD) related seeds quantitative detector (AD-seeds-detector), and their sensitivity and specificity in diagnosing AD, compared with those from age-matched cognitively normal controls, and those with other types of dementia. To perform a high …

55 - 75 years of age All Phase N/A

Study on Biomarkers for Early Diagnosis of Alzheimer's Disease

The project of Bio-AD is a population- based cohort study among the elderly in China. The project includes not only Alzheimer's disease (AD including familial AD and sporadic AD), but also other clinical stage of AD, as well as elderly people with normal cognitive function. The project will collect, detect …

18 years of age All Phase N/A
T Trisha Walsh

Arizona Alzheimer's Disease Research Center (ADRC)

The Arizona Alzheimer's Disease Research Center (ADRC) is the National Institute on Aging's (NIA's) first statewide AD Center (ADC), the only ADC in the Southwestern United States, and a leading example of statewide collaboration in biomedical research. It capitalizes on Arizona's strengths in brain imaging, genomics, computer science and biomathematics, …

40 years of age All Phase N/A
X Xiu Han, Doctor

The Chinese Familial Alzheimer's Network

This research will establish and continuously improve the FAD research network in conjunction with multi-center institutions nationwide. By collecting information on the family's demography, genetics, neuropsychology, neuroimaging, biomarkers and other information, we can understand the current FAD population in China, clarify the genetic characteristics, pathogenesis, disease characteristics and diagnosis and …

18 years of age All Phase N/A
K Kelley Jackson

F 18 T807 Tau PET Imaging of Alzheimer's Disease

A single-center, open-label baseline controlled imaging study designed to assess whether brain tau fibril uptake of flortaucipir as measured by PET correlates with cognitive status of individuals with and without brain tau fibrils.

18 years of age All Phase N/A

Alzheimer's Prevention Registry: A Program to Accelerate Enrollment Into Studies

The Alzheimer's Prevention Registry (www.endALZnow.org) will collect contact and demographic information on individuals. The objective is to provide information the latest news and advances in Alzheimer's prevention research, and to inform enrollees about research studies in their community. Enrolled individuals will receive regular email communications. As research studies become available, …

18 - 110 years of age All Phase N/A
G Go to Site Finder https://www.alz-net.org/Find-a-Site

Alzheimer's National Registry for Treatment and Diagnostics(ALZ-NET)

The Alzheimer's Network for Treatment and Diagnostics (ALZ-NET) will collect longitudinal clinical and safety data for enrolled patients being evaluated for or treated with novel FDA-approved Alzheimer's disease (AD) therapies. ALZ-NET is a longitudinal registry with an expandable platform, designed to grow with scientific and medical advancements. As new treatments …

18 years of age All Phase N/A
T Tengfei Guo, Ph.D.

Greater-Bay-Area Healthy Aging Brain Study (GHABS)

The goal of this observational study is to learn about the pathophysiology characterization and evolutionary patterns of Alzheimer's disease (AD) in South China older adults. The primary purposes are as follows: The prevalence and characteristics of AD in South China's aging population Identify novel biomarkers and neuroimaging techniques for early …

55 - 90 years of age All Phase N/A
D Dolly Reyes-Dumeyer

Late Onset Alzheimer's Disease

The goal of this study is to is to focus on the genetic influences on Alzheimer's Disease (AD) risk. The investigators are looking for families and/or individuals (affected or unaffected) of any ethic background (African American, Caucasian, and Hispanics) with a family history of AD and willing to participate.

55 years of age All Phase N/A

Simplify language using AI